Your browser doesn't support javascript.
loading
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
Tan, Catherine L; Kuchroo, Juhi R; Sage, Peter T; Liang, Dan; Francisco, Loise M; Buck, Jessica; Thaker, Youg Raj; Zhang, Qianxia; McArdel, Shannon L; Juneja, Vikram R; Lee, Sun Jung; Lovitch, Scott B; Lian, Christine; Murphy, George F; Blazar, Bruce R; Vignali, Dario A A; Freeman, Gordon J; Sharpe, Arlene H.
Afiliación
  • Tan CL; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Kuchroo JR; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Sage PT; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Liang D; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Francisco LM; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Buck J; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Thaker YR; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Zhang Q; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • McArdel SL; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Juneja VR; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Lee SJ; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Lovitch SB; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Lian C; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
  • Murphy GF; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
  • Blazar BR; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, UK.
  • Vignali DAA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Freeman GJ; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.
  • Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
J Exp Med ; 218(1)2021 01 04.
Article en En | MEDLINE | ID: mdl-33045061
ABSTRACT
Inhibitory signals through the PD-1 pathway regulate T cell activation, T cell tolerance, and T cell exhaustion. Studies of PD-1 function have focused primarily on effector T cells. Far less is known about PD-1 function in regulatory T (T reg) cells. To study the role of PD-1 in T reg cells, we generated mice that selectively lack PD-1 in T reg cells. PD-1-deficient T reg cells exhibit an activated phenotype and enhanced immunosuppressive function. The in vivo significance of the potent suppressive capacity of PD-1-deficient T reg cells is illustrated by ameliorated experimental autoimmune encephalomyelitis (EAE) and protection from diabetes in nonobese diabetic (NOD) mice lacking PD-1 selectively in T reg cells. We identified reduced signaling through the PI3K-AKT pathway as a mechanism underlying the enhanced suppressive capacity of PD-1-deficient T reg cells. Our findings demonstrate that cell-intrinsic PD-1 restraint of T reg cells is a significant mechanism by which PD-1 inhibitory signals regulate T cell tolerance and autoimmunity.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Transducción de Señal / Linfocitos T Reguladores / Diabetes Mellitus Experimental / Encefalomielitis Autoinmune Experimental / Receptor de Muerte Celular Programada 1 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2021 Tipo del documento: Article País de afiliación: Marruecos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Transducción de Señal / Linfocitos T Reguladores / Diabetes Mellitus Experimental / Encefalomielitis Autoinmune Experimental / Receptor de Muerte Celular Programada 1 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Exp Med Año: 2021 Tipo del documento: Article País de afiliación: Marruecos